Low-dose aspirin can reduce inflammatory responses to sleep restriction

FHS
June 3, 2024
7:11 pm

A new study to be presented at the SLEEP 2024 annual meeting found that low-dose acetylsalicylic acid, also known as aspirin, can reduce inflammatory responses to sleep restriction.

SciRhom secures $70m to develop autoimmune diseases therapies

The investment will expedite the development of SciRhom’s therapeutic strategy, which focuses on autoimmune disorders. Credit: Pickadook / Shutterstock. German biopharmaceutical company SciRhom has secured

July 9, 2024

New imaging technique provides a much closer look at fibril assemblies

A new imaging technique developed by engineers at Washington University in St. Louis can give scientists a much closer look at fibril assemblies, stacks of

April 27, 2024

A Look at Food-Related Illnesses at Restaurants Over the Years

Outbreaks of foodborne illnesses are pretty rare for well-known restaurant chains, but they do happen. This week, an outbreak of Escherichia coli food poisonings linked

October 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.